|
|
||||||||
American Journal of Roentgenology, Vol 165, 91-95, Copyright © 1995 by American Roentgen Ray Society
ARTICLES |
WW Mayo-Smith, MJ Lee, MM McNicholas, PF Hahn, GW Boland and S Saini
Department of Radiology, Massachusetts General Hospital, Boston, USA.
OBJECTIVE. The purposes of this study were to evaluate the ability of chemical shift MR imaging to differentiate 1- to 5-cm adrenal adenomas from metastases and to compare subjective interpretation with several different quantitative measures. SUBJECTS AND METHODS. Forty-three patients with 46 proved adrenal lesions (28 adenomas and 18 metastases) had MR imaging with a gradient-echo breath-hold technique and echo time varied to obtain in-phase and out-of-phase images. Qualitative analysis of the MR images was done by three experienced observers, who reported their confidence in diagnosing the benignity versus the malignancy of the adrenal masses on the basis of signal loss on out-of-phase images. Quantitative analysis was performed by calculating the difference in signal intensity between in-phase and out-of-phase images by use of regions of interest (signal intensity index) and by use of adrenal- liver, adrenal-spleen, and adrenal-muscle signal intensity ratios. Results between quantitative and qualitative measures were compared by use of receiver operating characteristic (ROC) analysis. RESULTS. The mean signal intensity was significantly different between adenomas and metastases on out-of-phase images (64 versus 98) (p < .0005) but not in- phase images (130 versus 122) (p = .47). The adrenal-spleen ratio discriminated between adenomas and metastases better than did the adrenal-liver ratio, the adrenal-muscle ratio, or the signal intensity index. No significant difference in interpretation among the three observers was evident (areas under the ROC curves, 0.93, 0.95, and 0.96). The performance of the observers was comparable to the results obtained with the adrenal-spleen ratio measurement (area under the ROC curve, 0.97). CONCLUSION. Experienced observers were able to differentiate adrenal adenomas from metastases just as well as quantitative measures. The adrenal-spleen ratio is the best quantitative means of distinguishing benign from malignant adrenal masses. Chemical shift MR imaging is a good but imperfect discriminator of adrenal adenomas.
This article has been cited by other articles:
![]() |
S. T. Schindera, B. J. Soher, D. M. Delong, B. M. Dale, and E. M. Merkle Effect of Echo Time Pair Selection on Quantitative Analysis for Adrenal Tumor Characterization with In-Phase and Opposed-Phase MR Imaging: Initial Experience Radiology, July 1, 2008; 248(1): 140 - 147. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Song, F. S. Chaudhry, and W. W. Mayo-Smith The Incidental Adrenal Mass on CT: Prevalence of Adrenal Disease in 1,049 Consecutive Adrenal Masses in Patients with No Known Malignancy Am. J. Roentgenol., May 1, 2008; 190(5): 1163 - 1168. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Song, F. S. Chaudhry, and W. W. Mayo-Smith The Incidental Indeterminate Adrenal Mass on CT (> 10 H) in Patients Without Cancer: Is Further Imaging Necessary? Follow-Up of 321 Consecutive Indeterminate Adrenal Masses Am. J. Roentgenol., November 1, 2007; 189(5): 1119 - 1123. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. S. Jhaveri, F. Wong, S. Ghai, and M. A. Haider Comparison of CT histogram analysis and chemical shift MRI in the characterization of indeterminate adrenal nodules. Am. J. Roentgenol., November 1, 2006; 187(5): 1303 - 1308. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Chong, K. S. Lee, H. Y. Kim, Y. K. Kim, B.-T. Kim, M. J. Chung, C. A Yi, and G. Y. Kwon Integrated PET-CT for the Characterization of Adrenal Gland Lesions in Cancer Patients: Diagnostic Efficacy and Interpretation Pitfalls RadioGraphics, November 1, 2006; 26(6): 1811 - 1824. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Kim, S. H. Kim, Y. J. Jang, H. Ahn, C.-S. Kim, H. Park, J. W. Lee, S. Kim, and K.-S. Cho Renal Angiomyolipoma with Minimal Fat: Differentiation from Other Neoplasms at Double-Echo Chemical Shift FLASH MR Imaging Radiology, April 1, 2006; 239(1): 174 - 180. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Blake, J. M. A. Slattery, M. K. Kalra, E. F. Halpern, A. J. Fischman, P. R. Mueller, and G. W. Boland Adrenal Lesions: Characterization with Fused PET/CT Image in Patients with Proved or Suspected Malignancy--Initial Experience Radiology, March 1, 2006; 238(3): 970 - 977. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Metser, E. Miller, H. Lerman, G. Lievshitz, S. Avital, and E. Even-Sapir 18F-FDG PET/CT in the Evaluation of Adrenal Masses J. Nucl. Med., January 1, 2006; 47(1): 32 - 37. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Savci, Z. Yazici, N. Sahin, S. Akgoz, and E. Tuncel Value of Chemical Shift Subtraction MRI in Characterization of Adrenal Masses Am. J. Roentgenol., January 1, 2006; 186(1): 130 - 135. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. K. Hussain, T. L. Chenevert, F. J. Londy, V. Gulani, S. D. Swanson, B. J. McKenna, H. D. Appelman, S. Adusumilli, J. K. Greenson, and H. S. Conjeevaram Hepatic Fat Fraction: MR Imaging for Quantitative Measurement and Display--Early Experience Radiology, December 1, 2005; 237(3): 1048 - 1055. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Elsayes, G. Mukundan, V. R. Narra, J. S. Lewis Jr, A. Shirkhoda, A. Farooki, and J. J. Brown Adrenal Masses: MR Imaging Features with Pathologic Correlation RadioGraphics, October 1, 2004; 24(suppl_1): S73 - S86. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Israel, M. Korobkin, C. Wang, E. N. Hecht, and G. A. Krinsky Comparison of Unenhanced CT and Chemical Shift MRI in Evaluating Lipid-Rich Adrenal Adenomas Am. J. Roentgenol., July 1, 2004; 183(1): 215 - 219. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Haider, S. Ghai, K. Jhaveri, and G. Lockwood Chemical Shift MR Imaging of Hyperattenuating (>10 HU) Adrenal Masses: Does It Still Have a Role? Radiology, June 1, 2004; 231(3): 711 - 716. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Mansmann, J. Lau, E. Balk, M. Rothberg, Y. Miyachi, and S. R. Bornstein The Clinically Inapparent Adrenal Mass: Update in Diagnosis and Management Endocr. Rev., April 1, 2004; 25(2): 309 - 340. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Fujiyoshi, M. Nakajo, Y. Fukukura, and S. Tsuchimochi Characterization of Adrenal Tumors by Chemical Shift Fast Low-Angle Shot MR Imaging: Comparison of Four Methods of Quantitative Evaluation Am. J. Roentgenol., June 1, 2003; 180(6): 1649 - 1657. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Krinsky and G. Israel Nondysplastic Nodules That Are Hyperintense on T1-Weighted Gradient-Echo MR Imaging: Frequency in Cirrhotic Patients Undergoing Transplantation Am. J. Roentgenol., April 1, 2003; 180(4): 1023 - 1027. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. R. Dunnick and M. Korobkin Imaging of Adrenal Incidentalomas: Current Status Am. J. Roentgenol., September 1, 2002; 179(3): 559 - 568. [Full Text] [PDF] |
||||
![]() |
W. W. Mayo-Smith, G. W. Boland, R. B. Noto, and M. J. Lee State-of-the-Art Adrenal Imaging RadioGraphics, July 1, 2001; 21(4): 995 - 1012. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Namimoto, Y. Yamashita, K. Mitsuzaki, Y. Nakayama, O. Makita, M. Kadota, and M. Takahashi Adrenal Masses: Quantification of Fat Content with Double-Echo Chemical Shift In-Phase and Opposed-Phase FLASH MR Images for Differentiation of Adrenal Adenomas Radiology, March 1, 2001; 218(3): 642 - 646. [Abstract] [Full Text] |
||||
![]() |
R. S. Arellano, G. W. L. Boland, and P. R. Mueller Adrenal Biopsy in a Patient with Lung Cancer: Imaging Algorithm and Biopsy Indications, Technique, and Complications Am. J. Roentgenol., December 1, 2000; 175(6): 1613 - 1617. [Full Text] [PDF] |
||||
![]() |
E. M. Remer, N. Obuchowski, J. D. Ellis, T. W. Rice, D. J. Adelstein, and M. E. Baker Adrenal Mass Evaluation in Patients with Lung Carcinoma: A Cost-Effectiveness Analysis Am. J. Roentgenol., April 1, 2000; 174(4): 1033 - 1039. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Sohaib, P. D. Peppercorn, C. Allan, J. P. Monson, A. B. Grossman, G. M. Besser, and R. H. Reznek Primary Hyperaldosteronism (Conn Syndrome): MR Imaging Findings Radiology, February 1, 2000; 214(2): 527 - 531. [Abstract] [Full Text] |
||||
![]() |
R. N. Low, R. C. Semelka, S. Worawattanakul, G. D. Alzate, and J. S. Sigeti Extrahepatic Abdominal Imaging in Patients with Malignancy: Comparison of MR Imaging and Helical CT, with Subsequent Surgical Correlation Radiology, March 1, 1999; 210(3): 625 - 632. [Abstract] [Full Text] |
||||
![]() |
M. N. Hood, V. B. Ho, J. G. Smirniotopoulos, and J. Szumowski Chemical Shift: The Artifact and Clinical Tool Revisited RadioGraphics, March 1, 1999; 19(2): 357 - 371. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |